Through bioinformatics predictions combined with experimental validation, we identified a novel CXCL14 receptor, a G protein-coupled receptor named CCR7, which appears to be a critical mediator of CAF-driven chemoresistance in bladder cancer cells. Here, ACKR3 is linked to urinary bladder carcinoma.